'On consolidated basis
Quarter ended September 2025 compared with Quarter ended September 2024.
Net sales (including other operating income) of Divis Laboratories has increased 16.12% to Rs 2715 crore. Operating profit margin has jumped from 30.62% to 32.71%, leading to 24.02% rise in operating profit to Rs 888.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 41.62% to 36.33%. Employee cost increased from 12.96% to 13.73%. Other expenses rose from 14.88% to 15.51%.
Other income rose 36.79% to Rs 145 crore. PBIDT rose 25.67% to Rs 1033 crore. Provision for interest rose 700% to Rs 8 crore. Loan funds rose to Rs 90.00 crore as of 30 September 2025 from Rs 8.00 crore as of 30 September 2024. Inventories rose to Rs 3,433.00 crore as of 30 September 2025 from Rs 3,145.00 crore as of 30 September 2024. S...
Pleaselogin & subscribe to view the full report.
More Reports
|
|